Author Correction: Platelet‑rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy
Main Authors: | Himanshu Bansal, Jerry Leon, Jeremy L. Pont, David A. Wilson, Anupama Bansal, Diwaker Agarwal, Iustin Preoteasa |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-09-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-98365-2 |
Similar Items
-
Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy
by: Himanshu Bansal, et al.
Published: (2021-02-01) -
Intra-articular injection in the knee of adipose derived stromal cells (stromal vascular fraction) and platelet rich plasma for osteoarthritis
by: Himanshu Bansal, et al.
Published: (2017-06-01) -
Retraction Note to: Intra-articular injection in the knee of adipose derived stromal cells (stromal vascular fraction) and platelet rich plasma for osteoarthritis
by: Himanshu Bansal, et al.
Published: (2021-04-01) -
Platelet Rich STROMA, the Combination of PRP and tSVF and Its Potential Effect on Osteoarthritis of the Knee
by: Hieronymus P. Stevens, et al.
Published: (2020-07-01) -
Moving toward targeting the right phenotype with the right platelet-rich plasma (PRP) formulation for knee osteoarthritis
by: Isabel Andia, et al.
Published: (2021-03-01)